Emerging patterns of somatic mutations in cancer - PubMed (original) (raw)
Review
. 2013 Oct;14(10):703-18.
doi: 10.1038/nrg3539. Epub 2013 Sep 11.
Affiliations
- PMID: 24022702
- PMCID: PMC4014352
- DOI: 10.1038/nrg3539
Review
Emerging patterns of somatic mutations in cancer
Ian R Watson et al. Nat Rev Genet. 2013 Oct.
Abstract
Recent advances in technological tools for massively parallel, high-throughput sequencing of DNA have enabled the comprehensive characterization of somatic mutations in a large number of tumour samples. In this Review, we describe recent cancer genomic studies that have assembled emerging views of the landscapes of somatic mutations through deep-sequencing analyses of the coding exomes and whole genomes in various cancer types. We discuss the comparative genomics of different cancers, including mutation rates and spectra, as well as the roles of environmental insults that influence these processes. We highlight the developing statistical approaches that are used to identify significantly mutated genes, and discuss the emerging biological and clinical insights from such analyses, as well as the future challenges of translating these genomic data into clinical impacts.
Figures
Figure 1. Frequent mutations of epigenetic regulators and pre-mRNA splicing machinery in cancers
Representative genes involved in (A) chromatin remodelling, histone and DNA methylation (Me), acetylation (Ac), and ubiquitination (Ub), and (B) pre-mRNA splicing that were identified to be recurrently mutated in various types of cancers by whole-exome and whole-genome sequencing are displayed. Predicted consequences of mutations, either gain of function (GOF) or loss of function (LOF), are also shown.
Similar articles
- Beyond the exome: the role of non-coding somatic mutations in cancer.
Piraino SW, Furney SJ. Piraino SW, et al. Ann Oncol. 2016 Feb;27(2):240-8. doi: 10.1093/annonc/mdv561. Epub 2015 Nov 23. Ann Oncol. 2016. PMID: 26598542 Review. - Next-Generation Sequencing.
Le Gallo M, Lozy F, Bell DW. Le Gallo M, et al. Adv Exp Med Biol. 2017;943:119-148. doi: 10.1007/978-3-319-43139-0_5. Adv Exp Med Biol. 2017. PMID: 27910067 Review. - Advances in understanding cancer genomes through second-generation sequencing.
Meyerson M, Gabriel S, Getz G. Meyerson M, et al. Nat Rev Genet. 2010 Oct;11(10):685-96. doi: 10.1038/nrg2841. Nat Rev Genet. 2010. PMID: 20847746 Review. - Advances in computational approaches for prioritizing driver mutations and significantly mutated genes in cancer genomes.
Cheng F, Zhao J, Zhao Z. Cheng F, et al. Brief Bioinform. 2016 Jul;17(4):642-56. doi: 10.1093/bib/bbv068. Epub 2015 Aug 24. Brief Bioinform. 2016. PMID: 26307061 Free PMC article. Review. - A comparative assessment of clinical whole exome and transcriptome profiling across sequencing centers: implications for precision cancer medicine.
Van Allen EM, Robinson D, Morrissey C, Pritchard C, Imamovic A, Carter S, Rosenberg M, McKenna A, Wu YM, Cao X, Chinnaiyan A, Garraway L, Nelson PS. Van Allen EM, et al. Oncotarget. 2016 Aug 16;7(33):52888-52899. doi: 10.18632/oncotarget.9184. Oncotarget. 2016. PMID: 27167109 Free PMC article.
Cited by
- Landscape of MicroRNA Regulatory Network Architecture and Functional Rerouting in Cancer.
Hua X, Li Y, Pentaparthi SR, McGrail DJ, Zou R, Guo L, Shrawat A, Cirillo KM, Li Q, Bhat A, Xu M, Qi D, Singh A, McGrath F, Andrews S, Aung KL, Das J, Zhou Y, Lodi A, Mills GB, Eckhardt SG, Mendillo ML, Tiziani S, Wu E, Huang JH, Sahni N, Yi SS. Hua X, et al. Cancer Res. 2023 Jan 4;83(1):59-73. doi: 10.1158/0008-5472.CAN-20-0371. Cancer Res. 2023. PMID: 36265133 Free PMC article. - Enhancer Reprogramming Confers Dependence on Glycolysis and IGF Signaling in KMT2D Mutant Melanoma.
Maitituoheti M, Keung EZ, Tang M, Yan L, Alam H, Han G, Singh AK, Raman AT, Terranova C, Sarkar S, Orouji E, Amin SB, Sharma S, Williams M, Samant NS, Dhamdhere M, Zheng N, Shah T, Shah A, Axelrad JB, Anvar NE, Lin YH, Jiang S, Chang EQ, Ingram DR, Wang WL, Lazar A, Lee MG, Muller F, Wang L, Ying H, Rai K. Maitituoheti M, et al. Cell Rep. 2020 Oct 20;33(3):108293. doi: 10.1016/j.celrep.2020.108293. Cell Rep. 2020. PMID: 33086062 Free PMC article. - TALEN-Mediated Gene Targeting for Cystic Fibrosis-Gene Therapy.
Xia E, Zhang Y, Cao H, Li J, Duan R, Hu J. Xia E, et al. Genes (Basel). 2019 Jan 11;10(1):39. doi: 10.3390/genes10010039. Genes (Basel). 2019. PMID: 30641980 Free PMC article. - Psychological Impact of _TP53_-Variant-Carrier Newborns and Counselling on Mothers: A Pediatric Surveillance Cohort.
Gozdziejewski AS, Zotti CW, de Carvalho IAM, Dos Santos TC, de Santi Walter LR, Ogradowski KRP, Dammski KL, Komechen H, Mendes MC, de Souza EN, Paraizo MM, da Silva Parise IZ, Parise GA, Grion AL, Custódio G, Mello RG, Figueiredo BC. Gozdziejewski AS, et al. Cancers (Basel). 2022 Jun 15;14(12):2945. doi: 10.3390/cancers14122945. Cancers (Basel). 2022. PMID: 35740610 Free PMC article. - _Cis_-Acting Factors Causing Secondary Epimutations: Impact on the Risk for Cancer and Other Diseases.
Ruiz de la Cruz M, de la Cruz Montoya AH, Rojas Jiménez EA, Martínez Gregorio H, Díaz Velásquez CE, Paredes de la Vega J, de la Cruz Hernández-Hernández F, Vaca Paniagua F. Ruiz de la Cruz M, et al. Cancers (Basel). 2021 Sep 26;13(19):4807. doi: 10.3390/cancers13194807. Cancers (Basel). 2021. PMID: 34638292 Free PMC article. Review.
References
- Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646–74. - PubMed
- Stratton MR. Exploring the genomes of cancer cells: progress and promise. Science. 2011;331:1553–8. - PubMed
- Vogelstein B, Kinzler KW. The multistep nature of cancer. Trends in genetics : TIG. 1993;9:138–41. - PubMed
- Meyerson M, Gabriel S, Getz G. Advances in understanding cancer genomes through second-generation sequencing. Nature reviews. Genetics. 2010;11:685–96. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources